These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 10328251
21. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C. JAMA Neurol; 2016 Jan; 73(1):102-10. PubMed ID: 26569098 [Abstract] [Full Text] [Related]
24. Visual processing disorders in patients with Huntington's disease and asymptomatic carriers. Gómez-Tortosa E, del Barrio A, Barroso T, García Ruiz PJ. J Neurol; 1996 Mar; 243(3):286-92. PubMed ID: 8936361 [Abstract] [Full Text] [Related]
27. Cognitive decline in Huntington's disease expansion gene carriers. Baake V, Reijntjes RHAM, Dumas EM, Thompson JC, REGISTRY Investigators of the European Huntington's Disease Network, Roos RAC. Cortex; 2017 Oct; 95():51-62. PubMed ID: 28843844 [Abstract] [Full Text] [Related]
28. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. Mochel F, Charles P, Seguin F, Barritault J, Coussieu C, Perin L, Le Bouc Y, Gervais C, Carcelain G, Vassault A, Feingold J, Rabier D, Durr A. PLoS One; 2007 Jul 25; 2(7):e647. PubMed ID: 17653274 [Abstract] [Full Text] [Related]
32. Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden. Musso M, Westervelt HJ, Long JD, Morgan E, Woods SP, Smith MM, Lu W, Paulsen JS, PREDICT-HD Investigators of the Huntington Study Group. J Int Neuropsychol Soc; 2015 Jan 25; 21(1):8-21. PubMed ID: 26304055 [Abstract] [Full Text] [Related]
39. Early cognitive deficits in Swedish gene carriers of Huntington's disease. Robins Wahlin TB, Lundin A, Dear K. Neuropsychology; 2007 Jan 25; 21(1):31-44. PubMed ID: 17201528 [Abstract] [Full Text] [Related]